BR

Biswarup Roy

Active Director Director DIN 08216517
DIN 08216517 First appointment Sep 2018 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Sep 2018
Shareholding value Locked Premium profile

About Biswarup Roy

Biswarup Roy has 8 years in corporate governance. Holds Director role. Currently with 1 company, including Liminal Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08216517
Primary Designation Director
First Appointment 05 Sep 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedStatus
Liminal Pharma Private Limited U24239WB2018PTC227658
Director05 Sep 20182018Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Liminal Pharma Private Limited
Premium access

Shareholding and investment profile for Biswarup Roy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Biswarup Roy

Biswarup Roy has 8 years in corporate governance. Holds Director role. Currently with 1 company, including Liminal Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Biswarup Roy is associated with 1 company as Director.

Biswarup Roy has expertise in General Business.

Biswarup Roy has 8 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available